Latest news with #MichaelHayden
Express Tribune
3 days ago
- Politics
- Express Tribune
Why is Iran despised in USA?
Listen to article In the Soviet Union, after World War II, the government awarded mothers that gave birth to many babies. It was called the Order of Maternal Glory. The higher the number of babies, the higher the class of the award. The war was won on the back of the Russians, who had lost about 11 million soldiers in winning the war. Mother Russia wanted more Russians. They had a population collapse problem to deal with. I remember a similar speech I had the chance of watching here in Houston. The speech was delivered by a former CIA and NSA chief named Michael Hayden. In his typical Cold War driven mentality, he made the case that Russia today also suffered from a similar population problem and that Russia was again running out of Russians. Well, Israel has the same problem but not many talk about it. One of the ways Israel can collapse is also through population collapse. And that is where Iran comes into this equation. Iran is the only country in that region that has always defied American and Israeli pressure as well as their designs, at least after the 1979 revolution. The Arab world may not be willing to recognise Israel or may play this ready and not-yet-ready-to-recognise dance, they may also broadcast Al Jazeera, but truth be told, they are no threat to Israel or to American plans for the region. That is the reason they occasionally face mild critique from the US president and the US media but that is as far as they go. Iran may not have the muscle to defeat Israel, it may not have the means to resist Israeli plans for the region, but it sure has the will and courage to resist those designs. Iran has refused to play by the rules of the American and the Israeli hegemonic games at every step of the way. But that is not the main reason why Iran is despised so much in the American power corridors. Iran has not only shown the capability to hit Israel but has also shown the will to do that despite the overwhelmingly dangerous repercussions. People move to Israel from other parts of the world especially the United States and Europe because they believe in Zionism, and they want a free home by taking over Palestinian homes. Think about it for a moment; if Israel becomes this dangerous place that can be hit anytime the Iranians want to, then no educated and wealthy Jew who wants to settle in Israel for Zionism would want to go there, even if the house is free. And certainly not if the house would have to be purchased. If you look at the Israeli literature, that is one of the main worries they also express. If Israel is turned into this ghetto where life and property are not safe then no Jewish family with resources and education would want to settle there, even for the sake of Zionism. Israel would face a population collapse problem just like the Russians did. But the Russians faced that problem due to millions of deaths in war, the Israelis would simply mass migrate elsewhere, in search of safe havens. Only the ones who don't have the resources to move out and the ones who wouldn't mind living in the ghettos would stay. And if we know even just a little by looking at any country, the poor and the unwanted citizens have never been the ones any government ever cared about. They will eventually resemble the Palestinians. Nobody would care about their plight. Israel will become this land filled with ghettos separated by vast distances of nothing in between. Just paved roads from the glorious past when no country dared attacking this fake state and America was always willing to bend backwards for Israel's war thirsty bratty attitude. And very simply; whomever Israel despises, American politicians and the American media would also despise. That's how things work in America.
National Post
10-07-2025
- Business
- National Post
Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation
Article content VANCOUVER, British Columbia — Life Sciences BC (LSBC) is pleased to announce the recipients of the 27th Annual Life Sciences BC Awards. These awards honour the exceptional achievements of individuals and organizations across British Columbia's life sciences sector that have successfully advanced health innovations and significantly enriched our dynamic ecosystem. Article content Award winners will be recognized in person at the 27th Annual Life Sciences BC Awards Gala on October 2, 2025, at the Vancouver Convention Centre West. This is a memorable evening where the life sciences community's most influential figures gather to celebrate excellence. Learn more and get your tickets before the early bird deadline on July 31, 2025, here. 2025 Life Sciences BC Awards Winners Company & Organizational Awards Company of the Year: Zymeworks Emerging Company of the Year – Biotech: Variational AI Emerging Company of the Year – MedTech: Arbutus Medical Strategic Partner of the Year: Providence Health Care Ventures Deal of the Year: NanoVation Therapeutics Individual Awards Dr. Don Rix Lifetime Achievement Award: Dr. Michael Hayden Milton Wong Community Leadership Award: Ali Ardakani Scientific Entrepreneurship Award: Dr. Poul Sorensen Genome British Columbia Award for Scientific Excellence: Dr. Fiona Brinkman Companies to Watch – Recognition Honour Roll*: Avee Health CereCura Nanotherapeutics GuideStar Medical Devices Optigo Biotherapeutics Phyton Biotech * Note: This is not a competitive award category but a recognition of emerging companies demonstrating significant potential within the BC life sciences ecosystem. 'Being named Life Sciences BC's 2025 Company of the Year is a tremendous honour and a reflection of the commitment to scientific innovation and collaboration here at Zymeworks,' said Dr. Paul Moore, Chief Scientific Officer, Zymeworks. 'Over the past year, we have seen the true impact of our world-class R&D engine on patients with limited treatment options, including the FDA approval of zanidatamab as the first HER2-targeted bispecific antibody for HER2-positive biliary tract cancer. This milestone would not have been possible without our team's exemplary scientific expertise, and we are proud that innovation developed here in British Columbia is helping to deliver novel therapies to patients around the world, who inspire our work each day.' Article content Article content 'We're proud to recognize individuals and organizations that have dedicated their talents to advancing our sector. I'm extremely excited about this year's award recipients. Advances in therapeutics, AI in drug discovery, medical devices, technology commercialization, and lipid nanoparticles stood out this year. Congratulations to Dr. Michael Hayden, Ali Ardakani, Dr. Poul Sorensen, and Dr. Fiona Brinkman for their incredible leadership within our vibrant life sciences community. ' – Wendy Hurlburt, President & CEO, Life Sciences BC. Article content Technology Sponsor Article content Farris Article content Event Supporter Article content Stem Cell Network Article content For sponsorship opportunities for the 27th Annual LSBC Awards Gala, please get in touch with Joanne Lin, Manager, Memberships & Sponsorships, at jlin@ Article content Life Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia's life sciences ecosystem through strategic initiatives at the local, national, and international levels. We drive economic growth in the province by providing leadership, fostering investment and partnerships, collaborating with government, and promoting BC's world-class life sciences sector. Article content Article content Article content Article content
Business Wire
10-07-2025
- Business
- Business Wire
Life Sciences BC Announces 2025 Awards Winners, Honouring Excellence in Health Innovation
VANCOUVER, British Columbia--(BUSINESS WIRE)--Life Sciences BC (LSBC) is pleased to announce the recipients of the 27th Annual Life Sciences BC Awards. These awards honour the exceptional achievements of individuals and organizations across British Columbia's life sciences sector that have successfully advanced health innovations and significantly enriched our dynamic ecosystem. "We're proud to recognize individuals and organizations that have dedicated their talents to advancing our sector. I'm extremely excited about this year's award recipients." - Wendy Hurlburt, Life Sciences BC President & CEO Share Award winners will be recognized in person at the 27th Annual Life Sciences BC Awards Gala on October 2, 2025, at the Vancouver Convention Centre West. This is a memorable evening where the life sciences community's most influential figures gather to celebrate excellence. Learn more and get your tickets before the early bird deadline on July 31, 2025, here. 2025 Life Sciences BC Awards Winners Company & Organizational Awards Company of the Year: Zymeworks Emerging Company of the Year - Biotech: Variational AI Variational AI Emerging Company of the Year - MedTech: Arbutus Medical Arbutus Medical Strategic Partner of the Year: Providence Health Care Ventures Providence Health Care Ventures Deal of the Year: NanoVation Therapeutics Individual Awards Dr. Don Rix Lifetime Achievement Award: Dr. Michael Hayden Dr. Michael Hayden Milton Wong Community Leadership Award: Ali Ardakani Ali Ardakani Scientific Entrepreneurship Award: Dr. Poul Sorensen Dr. Poul Sorensen Genome British Columbia Award for Scientific Excellence: Dr. Fiona Brinkman Companies to Watch – Recognition Honour Roll*: Avee Health CereCura Nanotherapeutics GuideStar Medical Devices Optigo Biotherapeutics Phyton Biotech * Note: This is not a competitive award category but a recognition of emerging companies demonstrating significant potential within the BC life sciences ecosystem. 'Being named Life Sciences BC's 2025 Company of the Year is a tremendous honour and a reflection of the commitment to scientific innovation and collaboration here at Zymeworks,' said Dr. Paul Moore, Chief Scientific Officer, Zymeworks. 'Over the past year, we have seen the true impact of our world-class R&D engine on patients with limited treatment options, including the FDA approval of zanidatamab as the first HER2-targeted bispecific antibody for HER2-positive biliary tract cancer. This milestone would not have been possible without our team's exemplary scientific expertise, and we are proud that innovation developed here in British Columbia is helping to deliver novel therapies to patients around the world, who inspire our work each day.' 'We're proud to recognize individuals and organizations that have dedicated their talents to advancing our sector. I'm extremely excited about this year's award recipients. Advances in therapeutics, AI in drug discovery, medical devices, technology commercialization, and lipid nanoparticles stood out this year. Congratulations to Dr. Michael Hayden, Ali Ardakani, Dr. Poul Sorensen, and Dr. Fiona Brinkman for their incredible leadership within our vibrant life sciences community. " – Wendy Hurlburt, President & CEO, Life Sciences BC. Award Sponsors AbCellera Acuitas Therapeutics Genome British Columbia Providence Research / St. Paul's Foundation VGH & UBC Hospital Foundation Networking Reception Sponsor Canadian Alliance for Skills and Training in Life Sciences (CASTL) Technology Sponsor Farris Event Supporter Stem Cell Network For sponsorship opportunities for the 27th Annual LSBC Awards Gala, please get in touch with Joanne Lin, Manager, Memberships & Sponsorships, at jlin@ About Life Sciences BC Life Sciences BC (LSBC) is a not-for-profit sector association dedicated to advancing British Columbia's life sciences ecosystem through strategic initiatives at the local, national, and international levels. We drive economic growth in the province by providing leadership, fostering investment and partnerships, collaborating with government, and promoting BC's world-class life sciences sector.
